Robert M. Wilechansky

440 total citations · 1 hit paper
14 papers, 236 citations indexed

About

Robert M. Wilechansky is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Robert M. Wilechansky has authored 14 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 7 papers in Hepatology and 6 papers in Surgery. Recurrent topics in Robert M. Wilechansky's work include Liver Disease Diagnosis and Treatment (9 papers), Liver Disease and Transplantation (6 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Robert M. Wilechansky is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Liver Disease and Transplantation (6 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Robert M. Wilechansky collaborates with scholars based in United States, Switzerland and Spain. Robert M. Wilechansky's co-authors include Michelle T. Long, Tracey G. Simon, Kathleen E. Corey, Andrew T. Chan, Deborah J. Jones, Marissa Burgermaster, Raymond T. Chung, Rohit Loomba, Laura E. Dichtel and Karen K. Miller and has published in prestigious journals such as JAMA, Hepatology and Liver Transplantation.

In The Last Decade

Robert M. Wilechansky

13 papers receiving 233 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis

2024 48 citations Tracey G. Simon, Robert M. Wilechansky et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert M. Wilechansky United States	7	165	75	59	49	43	14	236
Lukas Binder Austria	5	188 1.1×	117 1.6×	63 1.1×	42 0.9×	23 0.5×	10	234
Soroor Owrangi United States	5	181 1.1×	114 1.5×	50 0.8×	42 0.9×	26 0.6×	5	225
Luis Miguel Vazquez‐Montesino United States	6	220 1.3×	123 1.6×	73 1.2×	75 1.5×	31 0.7×	7	288
Elmer Schabel Germany	6	236 1.4×	103 1.4×	120 2.0×	33 0.7×	43 1.0×	8	266
Jesús Rivera‐Esteban Spain	9	240 1.5×	107 1.4×	106 1.8×	27 0.6×	49 1.1×	28	278
Katherine Eberly United States	5	275 1.7×	104 1.4×	139 2.4×	30 0.6×	55 1.3×	9	328
Benjamin Nah Singapore	11	187 1.1×	67 0.9×	113 1.9×	17 0.3×	42 1.0×	25	271
Sofia Carvalhana Portugal	8	166 1.0×	56 0.7×	90 1.5×	37 0.8×	26 0.6×	17	211
Jacob George Australia	5	246 1.5×	116 1.5×	95 1.6×	46 0.9×	20 0.5×	17	322
Tudor Cuciureanu Romania	10	258 1.6×	76 1.0×	153 2.6×	32 0.7×	53 1.2×	52	361

Countries citing papers authored by Robert M. Wilechansky

Since Specialization

Citations

This map shows the geographic impact of Robert M. Wilechansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Wilechansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Wilechansky more than expected).

Fields of papers citing papers by Robert M. Wilechansky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert M. Wilechansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Wilechansky. The network helps show where Robert M. Wilechansky may publish in the future.

Co-authorship network of co-authors of Robert M. Wilechansky

This figure shows the co-authorship network connecting the top 25 collaborators of Robert M. Wilechansky. A scholar is included among the top collaborators of Robert M. Wilechansky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert M. Wilechansky. Robert M. Wilechansky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Wilechansky, Robert M.. (2025). Surging sludge: Intrahepatic cholangiocarcinoma mortality on the rise worldwide. Hepatology. 82(3). 543–544.

Sherman, Marc S., Eric M. Przybyszewski, Robert M. Wilechansky, et al.. (2024). A natural language processing algorithm accurately classifies steatotic liver disease pathology to estimate the risk of cirrhosis. Hepatology Communications. 8(4). 2 indexed citations

Simon, Tracey G., Robert M. Wilechansky, Laura E. Dichtel, et al.. (2024). Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis. JAMA. 331(11). 920–920. 48 indexed citations breakdown →

Przybyszewski, Eric M., Robert M. Wilechansky, Andrew S. Allegretti, et al.. (2024). Controversies in terlipressin and transplantation in the United States: How do we MELD the two?. Liver Transplantation. 30(7). 753–759. 1 indexed citations

Wilechansky, Robert M., Xuehong Zhang, Edward L. Giovannucci, et al.. (2023). The empirical dietary inflammatory pattern score and the risk of nonalcoholic fatty liver disease and cirrhosis. Hepatology Communications. 7(10). 9 indexed citations

Wang, Jeffrey, et al.. (2023). Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD. Hepatology Communications. 7(11). 10 indexed citations

Shih, Angela, Robert M. Wilechansky, Reece Goiffon, et al.. (2022). Persistent Cholestatic Injury and Secondary Sclerosing Cholangitis in COVID-19 Patients. Archives of Pathology & Laboratory Medicine. 146(10). 1184–1193. 13 indexed citations

Wilechansky, Robert M., et al.. (2021). Revamping Residency Education during a Pandemic with Twitter-Based Learning. Medical Science Educator. 31(2). 303–304. 4 indexed citations

Trivedi, Hirsh D., Robert M. Wilechansky, Andrew Canakis, et al.. (2021). Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19. Gastroenterology Research. 14(3). 179–183. 4 indexed citations

10.

Wilechansky, Robert M., et al.. (2019). Eosinophilic esophagitis, gastroenteritis, and colitis in a patient with prior parasite exposure. Clinical Journal of Gastroenterology. 12(6). 530–533. 1 indexed citations

11.

Wilechansky, Robert M., et al.. (2019). Nonalcoholic Fatty Liver Disease and Obesity Treatment. Current Obesity Reports. 8(3). 220–228. 106 indexed citations

12.

Wilechansky, Robert M., Alison Pedley, Joseph M. Massaro, et al.. (2019). Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: A secondary analysis. Liver International. 39(8). 1535–1544. 19 indexed citations

13.

Wilechansky, Robert M., Marissa Burgermaster, Deborah J. Jones, & David S. Seres. (2016). Obesity, Diet, and Exercise Education for the Primary Care Clerkship Using an Articulate Storyline 2 e-Learning Module. MedEdPORTAL. 12. 10497–10497. 15 indexed citations

14.

Wilechansky, Robert M., et al.. (2016). Disrupted pancreatic duct treated with a combination of endoscopic cystoduodenostomy and pancreatic duct fistualization through a pseudocyst wall using a lumen‐apposing metal stent. Digestive Endoscopy. 29(2). 226–228. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact